Bristol-Myers, Celgene Shares Both Lower as Merger Faces Delays

Date : 06/24/2019 @ 8:30PM
Source : Dow Jones News
Stock : Bristol-Myers Squibb Company (BMY)
Quote : 43.33  -0.72 (-1.63%) @ 12:13AM

Bristol-Myers, Celgene Shares Both Lower as Merger Faces Delays

Bristol Myers Sqibb (NYSE:BMY)
Historical Stock Chart

1 Month : From Jun 2019 to Jul 2019

Click Here for more Bristol Myers Sqibb Charts.

By Stephen Nakrosis


Shares of Bristol-Myers Squibb Co. (BMY) and Celgene Corp. (CELG) are both in the red in Monday's market, following news their planned merger would be delayed due to antitrust concerns.

At 2:51 p.m. ET, Bristol-Myers Squibb shares had lost 7.4%, to trade at $45.69. Volume was heavier than usual, with over 29.1 million shares trading, above the 65-day average volume of some 14.6 million. Celgene shares had lost 5.34%, trading at $93.63. That stock's volume was also higher than usual with over 7.2 million shares trading, above its 65-day average volume of some 6.6 million.

The $74 billion merger faces delays as the companies work to sell Celgene's anti-inflammatory drug, Otzela, in an effort to address concerns raised by antitrust regulators.


--Write to Stephen Nakrosis at


(END) Dow Jones Newswires

June 24, 2019 15:15 ET (19:15 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest BMY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.